SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-093612
Filing Date
2022-04-01
Accepted
2022-04-01 16:05:58
Documents
11
Period of Report
2022-05-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A d287450ddef14a.htm DEF 14A 589488
2 GRAPHIC g287450g02a02.jpg GRAPHIC 42806
3 GRAPHIC g287450g19i71.jpg GRAPHIC 8415
4 GRAPHIC g287450g59a59.jpg GRAPHIC 34553
5 GRAPHIC g287450g69f51.gif GRAPHIC 391
6 GRAPHIC g287450g80w12.jpg GRAPHIC 113808
7 GRAPHIC g287450pc0001.jpg GRAPHIC 2030
8 GRAPHIC g287450pc0002.jpg GRAPHIC 947
9 GRAPHIC g287450pc0003.jpg GRAPHIC 864
10 GRAPHIC g287450pc0004.jpg GRAPHIC 1213
11 GRAPHIC g287450pc0005.jpg GRAPHIC 1001
  Complete submission text file 0001193125-22-093612.txt   862539
Mailing Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1
Business Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1 (857) 412-7018
Repare Therapeutics Inc. (Filer) CIK: 0001808158 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39335 | Film No.: 22798222
SIC: 2834 Pharmaceutical Preparations